Latest News of INBX
The recent drop in prices must have disappointed Inhibrx Biosciences, Inc. (NASDAQ:INBX) institutional investors who own 43% of the shares
By Yahoo! Finance |
5 days ago
Inhibrx Biosciences has 7 investors with a majority stake of 50%. Institutions hold 43% ownership, facing the biggest gain or loss. Hedge funds and individuals also hold significant stakes, with Vikin...
Director Kristiina Vuori Purchases Shares of Inhibrx Biosciences Inc (INBX)
By Yahoo! Finance |
2 months ago
Inhibrx Biosciences Inc (NASDAQ:INBX) is a biotech company developing therapeutic candidates for various medical needs. Recent insider transactions show more buying than selling, indicating confidence...